Experts seek WHO nod for postpartum haemorrhage drug

(Image: Wikimedia Commons)

Health groups are urging WHO to include misoprostol for the prevention and management of postpartum haemorrhage (PPH), or excessive bleeding following childbirth. WHO in 2009 denied misoprostol for prevention of PPH but proponents hope new evidence presented for the 21-25 March WHO meeting in the Ghanaian capital Accra will bring a change.

Read the article.